Assessment of Panobacumab as Adjunctive Immunotherapy for the Treatment of Nosocomial Pseudomonas Aeruginosa Pneumonia

European Journal of Clinical Microbiology and Infectious Diseases - Germany
doi 10.1007/s10096-014-2156-1